Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
45,180,042
-
Share change
-
+2,887,245
-
Total reported value
-
$1,899,011,487
-
Put/Call ratio
-
44%
-
Price per share
-
$42.00
-
Number of holders
-
206
-
Value change
-
+$119,111,509
-
Number of buys
-
106
-
Number of sells
-
99
Institutional Holders of ARENA PHARMECEUTICALS INC - COMMON STOCK (ARNA) as of Q1 2020
As of 31 Mar 2020,
ARENA PHARMECEUTICALS INC - COMMON STOCK (ARNA) was held by
206 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
45,180,042 shares.
The largest 10 holders included
BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, STATE STREET CORP, CITADEL ADVISORS LLC, ALLIANCEBERNSTEIN L.P., FMR LLC, EAGLE ASSET MANAGEMENT INC, LORD, ABBETT & CO. LLC, and NORGES BANK.
This page lists
206
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.